Donate | Print Page | Contact Us | Report Abuse | Sign In | Join/Renew
Board of Directors

There shall be twelve directors who, in addition to five officers, shall constitute the Board of Directors. There shall be balanced representation among academia, government and industry and voluntary health organizations on the Board of Directors. The Board of Directors shall manage the property and affairs of the Organization subject to these Bylaws.

 

OFFICERS

President
Thomas P. Sutula, M.D., Ph.D.
University of Wisconsin - Madison
President Elect
TBD
Secretary
TBD

Treasurer
O’Neill D’Cruz, M.D., MBA, FAAN
OD Consulting and Neurological Services, PLLC

Immediate Past President
Martha Morrell, M.D.
NeuroPace, Inc
   

BOARD OF DIRECTORS


Enrique J. Carrazana, M.D. Mariunus Pharma

Amy S. Chappell, M.D., Eliem Therapeutics and Carnot Biosciences

Gail Farfel, Ph.D. Zogenyx, Inc. 
Stewart A. Factor, D.O.
Emory University School
of Medicine

Toby Ferguson, M.D., Ph.D.
Biogen Idec, Inc

Lindsey Lair, M.D. Janssen
Bennett L, Lavenstein, M.D.
Co-Chair
Children’s Hospital Medical
Center

John R. Richert, M.D.
Richert Partners

Steven Schachter, M.D.
CIMIT/Harvard Medical
School

David Shoup
The Curry Rockefeller Group
 
   

EX-OFFICIO BOARD MEMBERS

Development
Committee Chair
Martha Morrell, M.D.
NeuroPace, Inc
Neurotherapeutics®
Editor-in-Chief
M. Maral Mouradian, M.D.
Rutgers University

Program Committee
Chair
C. Anthony Altar, Ph.D. Verge Genomics 
NIH Training in Neurotherapeutics Course Liaison
Barbara Slusher, Ph.D., MAS
John Hopkins Brain Science
Institute
Federal Liaison
Amir Tamiz, Ph.D.
NIH, NINDS, OTR
 
  Communications
Terrie Blalock, RN, MS
TBlalock Consulting
 

   

EXECUTIVE STAFF

Executive Director
Jessica Keenan Smith
ASENT

 










American Society for Experimental Neurotherapeutics
230 Kings Highway East, Ste 245
Haddonfield, NJ 08033
p: 833.273.6800
e:caroline@asent.org

  Connect with Us: